Patents by Inventor Ulf Sjobring

Ulf Sjobring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein L and hybrid proteins thereof
    Patent number: 6822075
    Abstract: The invention relates to sequences of protein L which bind to light chains of immunoglobulins. The invention also relates to hybrid proteins thereof which are able to bind to both light and heavy chains of immunoglobulin G, in particular protein LG. The invention also relates to DNA-sequences which code for the proteins, vectors which include such DNA-sequences, host cells which have been transformed with the vectors, methods for producing the proteins, reagent appliances for separation and identification of immunoglobulins, compositions and pharmaceutical compositions and pharmaceutical compositions which contain the proteins.
    Type: Grant
    Filed: October 26, 1994
    Date of Patent: November 23, 2004
    Assignee: Affitech AS
    Inventors: Lars Björck, Ulf Sjöbring
  • PROTEIN L AND HYBRID PROTEINS THEREOF
    Publication number: 20030027283
    Abstract: The invention relates to sequences of protein L which bind to light chains of immunoglobulins. The invention also relates to hybrid proteins thereof which are able to bind to both light and heavy chains of immunoglobulin G, in particular protein LG. The invention also relates to DNA-sequences which code for the proteins, vectors which include such DNA-sequences, host cells which have been transformed with the vectors, methods for producing the proteins, reagent appliances for separation and identification of immunoglobulins, compositions and pharmaceutical compositions and pharmaceutical compositions which contain the proteins.
    Type: Application
    Filed: October 26, 1994
    Publication date: February 6, 2003
    Inventors: LARS BJORCK, ULF SJOBRING
  • Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections
    Patent number: 6221845
    Abstract: Kinin antagonists, especially bradykinin antagonists, can be used for treating bacterial infections, in particular infections caused by bacteria belonging to the genera Streptococcus, Escherichia, Salmonella, Staphylococcus, Klebsiella, Moracella, Haemophilus and Yersinia.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: April 24, 2001
    Assignee: Actinova Limited
    Inventors: Lars Björck, Ulf Sjöbring, Abdelhakim Ben Nasr, Arne Olsén, Heiko Herwald, Werner Müller-Esterl
  • Protein L and hybrid proteins thereof
    Patent number: 5965390
    Abstract: The invention relates to sequences of protein L which bind to light chains of immunoglobulins. The invention also relates to hybrid proteins thereof which are able to bind to both light and heavy chains of immunoglobulin G, in particular protein LG. The invention also relates to DNA-sequences which code for the proteins, vectors which include such DNA-sequences, host cells which have been transformed with the vectors, methods for producing the proteins, reagent appliances for separation and identification of immunoglobulins, compositions and pharmaceutical compositions and pharmaceutical compositions which contain the proteins.
    Type: Grant
    Filed: February 11, 1997
    Date of Patent: October 12, 1999
    Assignee: Actinova Ltd.
    Inventors: Lars Bjorck, Ulf Sjobring